Accessibility Menu

3 Reasons MetLife Is Wasting Its Time Fighting the FSOC

As the insurer enters the third phase of the FSOC's review for Systemically Important Financial Institutions, its CEO is on the warpath to avoid the designation. But the company's wasting its time.

By Jessica Alling Jul 25, 2014 at 2:02PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.